Skip to content
healthcare.dev

DASATINIB

NDC 59651-547, DASATINIB, tablet, from Aurobindo Pharma Limited.

Product NDC
59651-547
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216547
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-547 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DASATINIB140 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
59651-547-15596510547151 BLISTER PACK in 1 CARTON (59651-547-15) / 15 TABLET in 1 BLISTER PACK
59651-547-305965105473030 TABLET in 1 BOTTLE (59651-547-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/58ce42c6-10bd-4bb4-bf89-eae8ed82c339

Use it

Look up 59651-547 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-547 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-547. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.